320 related articles for article (PubMed ID: 8702538)
21. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin.
Hanasaki K; Powell LD; Varki A
J Biol Chem; 1995 Mar; 270(13):7543-50. PubMed ID: 7706301
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis.
Vinson M; van der Merwe PA; Kelm S; May A; Jones EY; Crocker PR
J Biol Chem; 1996 Apr; 271(16):9267-72. PubMed ID: 8621587
[TBL] [Abstract][Full Text] [Related]
23. Sialylation of the sialic acid binding lectin sialoadhesin regulates its ability to mediate cell adhesion.
Barnes YC; Skelton TP; Stamenkovic I; Sgroi DC
Blood; 1999 Feb; 93(4):1245-52. PubMed ID: 9949167
[TBL] [Abstract][Full Text] [Related]
24. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling.
Jin L; McLean PA; Neel BG; Wortis HH
J Exp Med; 2002 May; 195(9):1199-205. PubMed ID: 11994425
[TBL] [Abstract][Full Text] [Related]
25. Sialoadhesin (Sn) maps to mouse chromosome 2 and human chromosome 20 and is not linked to the other members of the sialoadhesin family, CD22, MAG, and CD33.
Mucklow S; Hartnell A; Mattei MG; Gordon S; Crocker PR
Genomics; 1995 Jul; 28(2):344-6. PubMed ID: 8530048
[TBL] [Abstract][Full Text] [Related]
26. Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding.
Powell LD; Jain RK; Matta KL; Sabesan S; Varki A
J Biol Chem; 1995 Mar; 270(13):7523-32. PubMed ID: 7706299
[TBL] [Abstract][Full Text] [Related]
27. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
[TBL] [Abstract][Full Text] [Related]
28. Regulation of CD45 engagement by the B-cell receptor CD22.
Sgroi D; Koretzky GA; Stamenkovic I
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4026-30. PubMed ID: 7537381
[TBL] [Abstract][Full Text] [Related]
29. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
[TBL] [Abstract][Full Text] [Related]
30. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
[TBL] [Abstract][Full Text] [Related]
31. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily.
Floyd H; Ni J; Cornish AL; Zeng Z; Liu D; Carter KC; Steel J; Crocker PR
J Biol Chem; 2000 Jan; 275(2):861-6. PubMed ID: 10625619
[TBL] [Abstract][Full Text] [Related]
32. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis.
Zhang M; Varki A
Glycobiology; 2004 Nov; 14(11):939-49. PubMed ID: 15240561
[TBL] [Abstract][Full Text] [Related]
33. Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22.
Kelm S; Schauer R; Manuguerra JC; Gross HJ; Crocker PR
Glycoconj J; 1994 Dec; 11(6):576-85. PubMed ID: 7696861
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
Yousef GM; Ordon MH; Foussias G; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
[TBL] [Abstract][Full Text] [Related]
35. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
36. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells.
Stamenkovic I; Sgroi D; Aruffo A; Sy MS; Anderson T
Cell; 1991 Sep; 66(6):1133-44. PubMed ID: 1717156
[TBL] [Abstract][Full Text] [Related]
37. CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.
Schwartz-Albiez R; Dörken B; Monner DA; Moldenhauer G
Int Immunol; 1991 Jul; 3(7):623-33. PubMed ID: 1716973
[TBL] [Abstract][Full Text] [Related]
38. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
39. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
[TBL] [Abstract][Full Text] [Related]
40. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
